ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
57,280.01
-5.48%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.949
0.14%
Brent Oil
85.14
-0.88%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Royalty Pharma PLC (RPRX)

  7. Royalty Pharma PLC (RPRX) ニュース

RPRX Royalty Pharma PLC

27.70
0.00 (0.00%)
プレマーケット
最終更新日： 17:00:00
15分遅延
名称 銘柄コード 市場 種別
Royalty Pharma PLC RPRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.00 0.00% 27.70 17:00:00
始値 安値 高値 終値 前日終値
27.70
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1921:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
2024/4/1721:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
2024/2/2906:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
2024/2/1523:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1521:33EDGAR2Form 8-K - Current report
2024/2/1521:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
2024/2/0621:01EDGAR2Form 8-K - Current report
2024/1/3106:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
2024/1/1922:15GLOBERoyalty Pharma Announces Dividend Increase
2024/1/0821:18EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
2024/1/0406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:30EDGAR2Form 144 - Report of proposed sale of securities
2023/12/3006:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2806:31EDGAR2Form 8-K - Current report
2023/12/2803:05EDGAR2Form 8-K - Current report
2023/12/2006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:47EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2806:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
2023/11/1707:16EDGAR2Form 8-K - Current report
2023/11/1707:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1509:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
2023/11/1322:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
2023/11/0823:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:40EDGAR2Form 8-K - Current report
2023/11/0821:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
2023/10/1922:29EDGAR2Form 8-K - Current report
2023/10/1920:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
2023/10/1705:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend
2023/10/1205:15GLOBERoyalty Pharma To Announce Third Quarter 2023 Financial..
2023/10/0405:15EDGAR2Form 144 - Report of proposed sale of securities
2023/10/0405:15EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2121:25GLOBERoyalty Pharma Appoints Eric Schneider as Chief Technology..
2023/9/0605:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
2023/9/0605:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
2023/9/0521:25GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
2023/8/2419:30GLOBERoyalty Pharma and Ferring Pharmaceuticals Enter Into US..
2023/8/2414:15BWRoyalty Pharma and Ferring Pharmaceuticals Enter into US..
2023/8/1206:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1005:45EDGAR2Form 144 - Report of proposed sale of securities
2023/8/0906:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0906:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0822:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:31EDGAR2Form 8-K - Current report
2023/8/0820:00GLOBERoyalty Pharma Reports Second Quarter 2023 Results
2023/7/1905:15GLOBERoyalty Pharma to Announce Second Quarter 2023 Financial..
2023/7/1805:15GLOBERoyalty Pharma Declares Third Quarter 2023 Dividend
2023/7/1507:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

NASDAQ
RPRX
Royalty Pharma
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有